5-HT1A receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [11C] WAY100635 and [11C] MADAM PET

Psychiatry Research - Neuroimaging

Volumn 172, Issue 1, 2009, Pages 31-37

  Jovanovic, Hristina ^a   Karlsson, Per ^a   Cerin, Åsta ^a   Halldin, Christer ^a   Nordström, Anna Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HT1A receptor; 5 HTT; Gonadal hormones; Menstrual cycle; PET; Women

Indexed keywords

2 (2 DIMETHYLAMINOMETHYLPHENYLSULFANYL) 5 METHYLPHENYLAMINE C 11; CARBON 11; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE CARBONYL C 11; PROGESTERONE; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG RECEPTOR BINDING; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY;

ADULT; BENZYLAMINES; BRAIN; CARBON RADIOISOTOPES; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MENSTRUAL CYCLE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN;

EID: 62249093800     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2008.07.002     Document Type: Article

References (39)

1. Ballinger S. Stress as a factor in lowered estrogen levels in the early postmenopause. Annals of the New York Academy of Sciences 592 (1990) 95-113 discussion 123-133
2. Bergstrom M., Boethius J., Eriksson L., Greitz T., Ribbe T., and Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. Journal of Computer Assisted Tomography 5 (1981) 136-141
3. 123I]beta-CIT SPECT is unrelated to gender or menstrual cycle. Psychopharmacology (Berl) 183 (2005) 181-189
4. 3H]paroxetine. Neuroscience 27 (1988) 473-496
5. Crespo-Facorro B., Kim J., Andreasen N.C., Spinks R., O'Leary D.S., Bockholt H.J., Harris G., and Magnotta V.A. Cerebral cortex: a topographic segmentation method using magnetic resonance imaging. Psychiatry Research 100 (2000) 97-126
6. Farde L., Ito H., Swahn C.G., Pike V.W., and Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. Journal of Nuclear Medicine 39 (1998) 1965-1971
7. Filicori M., Butler J.P., and Crowley Jr. W.F. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. Jourbal of Clinical Investigation 73 (1984) 1638-1647
8. Filicori M., Santoro N., Merriam G.R., and Crowley Jr. W.F. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism 62 (1986) 1136-1144
9. FitzGerald M., Malone K.M., Li S., Harrison W.M., McBride P.A., Endicott J., Cooper T., and Mann J.J. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. American Journal of Psychiatry 154 (1997) 556-558
10. Fludder J.M., and Tonge S.R. Proceedings: variations in the concentrations of monamines and their metabolites in eight regions of rat brain during the oestrous cycle: a basis for interactions between hormones and psychotropic drugs. Journal of Pharmacy and Pharmacology 27 Suppl?-2 (1975) 39
11. Flugge G., Pfender D., Rudolph S., Jarry H., and Fuchs E. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. Journal of Neuroendocrinology 11 (1999) 243-249
12. Gorman J.M. Gender differences in depression and response to psychotropic medication. Gender Medicine 3 (2006) 93-109
13. Gregoire A.J., Kumar R., Everitt B., Henderson A.F., and Studd J.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347 (1996) 930-933
14. 11C]WAY-100635 for PET. Neuroimage 8 (1998) 426-440
15. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikstrom H., and Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research 745 (1997) 96-108
16. Halldin C., Lundberg J., Sovago J., Gulyas B., Guilloteau D., Vercouillie J., Emond P., Chalon S., Tarkiainen J., Hiltunen J., and Farde L. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse 58 (2005) 173-183
17. Jovanovic H., Cerin A., Karlsson P., Lundberg J., Halldin C., and Nordstrom A.L. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Research 148 (2006) 185-193
18. Krasikova R.N., Truong P., and Halldin C. A fully automated production of [carbolyl-11C]WAY-10035 for clinical PET studies. Journal of Labelled Compounds and Radiopharmaceuticals 46 (2003) 244
19. Kueng W., Wirz-Justice A., Menzi R., and Chappuis-Arndt E. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocrinology 21 (1976) 289-296
20. Lundberg J., Odano I., Olsson H., Halldin C., and Farde L. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Journal of Nuclear Medicine 46 (2005) 1505-1515
21. Lundberg J., Halldin C., and Farde L. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study. Synapse 60 (2006) 256-263
22. Maswood S., Truitt W., Hotema M., Caldarola-Pastuszka M., and Uphouse L. Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Research 831 (1999) 146-154
23. McQueen J.K., Wilson H., and Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Research Molecular Brain Research 45 (1997) 13-23
24. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., and Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biological Psychiatry 48 (2000) 854-860
25. Nordstrom A.L., Olsson H., and Halldin C. A PET study of D2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Research 83 (1998) 1-6
26. Parsey R.V., Arango V., Olvet D.M., Oquendo M.A., Van Heertum R.L., and John Mann J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism 25 (2005) 785-793
27. Pearlstein T., Rosen K., and Stone A.B. Mood disorders and menopause. Endocrinology and Metabolism Clinics of North America 26 (1997) 279-294
28. Pecins-Thompson M., and Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 89 (1999) 267-277
29. Pecins-Thompson M., Brown N.A., and Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Research Molecular Brain Research 53 (1998) 120-129
30. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. Journal of Clinical Psychiatry 60 Suppl 18 (1999) 4-15
31. Plenge P., Mellerup E.T., and Laursen H. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine. Progress in Neuro-psychopharmacology Biological Psychiatry 14 (1990) 61-72
32. Rossmanith W.G., Laughlin G.A., Mortola J.F., Johnson M.L., Veldhuis J.D., and Yen S.S. Pulsatile cosecretion of estradiol and progesterone by the midluteal phase corpus luteum: temporal link to luteinizing hormone pulses. Journal of Clinical Endocrinology and Metabolism 70 (1990) 990-995
33. Rubinow D.R., Schmidt P.J., and Roca C.A. Estrogen-serotonin interactions: implications for affective regulation. Biological Psychiatry 44 (1998) 839-850
34. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., and Rubinow D.R. Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics and Gynecology 183 (2000) 414-420
35. Slater P., Doyle C.A., and Deakin J.F. Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates. Journal of Neural Transmission 105 (1998) 305-315
36. Steiner M., Dunn E., and Born L. Hormones and mood: from menarche to menopause and beyond. Journal of Affective Disorders 74 (2003) 67-83
37. Su T.P., Schmidt P.J., Danaceau M., Murphy D.L., and Rubinow D.R. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology and Metabolism 82 (1997) 1220-1228
38. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., and Heiss W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. Journal of Computer Assisted Tomography 18 (1994) 110-118
39. Young E.A., Midgley A.R., Carlson N.E., and Brown M.B. Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry 57 (2000) 1157-1162